Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.
- TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450.
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.
- Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector.
- GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business.
- Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620.
- Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.
- EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.
- Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.
- Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.
- Marpai, Inc. (NASDAQ: MRAI) gained 18.7% to $2.0899.
- bioAffinity Technologies, Inc. (NASDAQ: BIAF) climbed 18.3% to $1.81.
- Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH) gained 15.6% to $4.8797.
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
- NWTN Inc. (NASDAQ: NWTN) gained 13.4% to $4.8082.
- Pulse Biosciences, Inc. (NASDAQ: PLSE) rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.
- Bilibili Inc. (NASDAQ: BILI) gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People's Congress event.
- Graphite Bio, Inc. (NASDAQ: GRPH) climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.
- STAAR Surgical Company (NASDAQ: STAA) jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.
- VNET Group, Inc. (NASDAQ: VNET) rose 9.8% to $1.68.
- Moderna, Inc. (NASDAQ: MRNA) gained 9.2% to $112.51.
- Ituran Location and Control Ltd. (NASDAQ: ITRN) climbed 7.8% to $28.42.
- NuScale Power Corporation(NYSE: SMR) gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.
- MicroStrategy Incorporated (NASDAQ: MSTR) gained 4.7% to $1,492.07 amid continued strength in Bitcoin.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Jeffs' Brands Ltd (NASDAQ: JFBR) fell 45.2% to $0.8650.
- Eltek Ltd. (NASDAQ: ELTK) shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.
- CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
- The Real Good Food Company, Inc. (NASDAQ: RGF) fell 19.7% to $0.5536.
- Ventyx Biosciences, Inc. (NASDAQ: VTYX) dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.
- Next.e.GO N.V. (NASDAQ: EGOX) declined 15.3% to $0.0727.
- MoneyLion Inc. (NYSE: ML) fell 15% to $63.36.
- Semilux International Ltd. (NASDAQ: SELX) fell 14.8% to $1.4403 after jumping 69% on Friday.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) fell 14.6% to $6.83.
- Barnes & Noble Education, Inc. (NYSE: BNED) dipped 13.8% to $0.7832. Barnes & Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.
- Psyence Biomedical Ltd. (NASDAQ: PBM) fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
- Immuron Limited (NASDAQ: IMRN) shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.
- Genie Energy Ltd. (NYSE: GNE) fell 12% to $16.67 following fourth-quarter results.
- Nanobiotix S.A. (NASDAQ: NBTX) dipped 9.8% to $6.35.
- Avenue Therapeutics, Inc. (NASDAQ: ATXI) fell 8.9% to $0.1749 after surging 10% on Friday.
- Super Micro Computer, Inc. (NASDAQ: SMCI) dipped 8.8% to $1,039.60.
- MannKind Corporation (NASDAQ: MNKD) declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
- Poseida Therapeutics, Inc. (NASDAQ: PSTX) fell 8.1% to $3.74.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Wall Street's Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.